Sanofi's Philippine effort marks first public campaign for dengue vaccine Dengvaxia

by Fierce Pharma Asia
April 4, 2016

A high-stakes rollout for Sanofi's ($SNY) Dengvaxia dengue vaccine was launched April 4 via a public effort in the Philippines aimed initially at 1 million schoolchildren. The Philippines is the first country to embark on a public campaign via the Department of Health and one of four that have approved the vaccine--which includes Brazil, Mexico and El Salvador--in efforts to limit the spread of the mosquito-borne disease. In a release, Sanofi said the 1 million students hailed from 6,000 public schools, with prospects to ramp up to 3 million under talks with the government for the two-dose vaccine.

Read more here